Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphomaReid W. Merryman, Jason T. Romancik, Lori Dahncke et al.|Leukemia|2021Cited by 83
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W. Merryman, Alex F. Herrera, Robert Redd et al.|Blood Advances|2021Cited by 51
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classical Hodgkin Lymphoma: Analysis of a Large International CohortReid W. Merryman, Massimo Magagnoli, Luca Castagna et al.|Blood|2019Cited by 8
Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin LymphomaReid W. Merryman, Alex F. Herrera, Robert Redd et al.|Blood|2019Cited by 2
Development of Cytokine Release Syndrome Is Associated with Superior Progression-Free Survival in DLBCL Patients Receiving Axi-Cel or Liso-CelMatthew Karr, Siobhan Larue, Michael A. Spinner et al.|Blood|2023Cited by 1